3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
21
Head & Neck
5
Breast
5
Thoracic
4
Gastrointestinal
4
Sarcoma
3
Lymphoid
2
Gynecologic
2
Dermatologic
2
Other solid neoplasm
1
Myeloid
1
CNS
1
Conditions
Ovarian Neoplasms
378
Endometrial Neoplasms
213
Uterine Cervical Neoplasms
207
Breast Neoplasms
115
Fallopian Tube Neoplasms
103
Colorectal Neoplasms
85
Carcinoma, Non-Small-Cell Lung
80
Neoplasms
67
Pancreatic Neoplasms
61
Stomach Neoplasms
54
Neoplasm Metastasis
52
Prostatic Neoplasms
51
Lung Neoplasms
48
Melanoma
44
Carcinoma, Ovarian Epithelial
43
Triple Negative Breast Neoplasms
40
Squamous Cell Carcinoma of Head and Neck
36
Carcinoma, Renal Cell
36
Esophageal Neoplasms
34
Colonic Neoplasms
31
Urinary Bladder Neoplasms
30
Peritoneal Neoplasms
30
Uterine Neoplasms
28
Head and Neck Neoplasms
28
Vulvar Neoplasms
26
Carcinoma, Hepatocellular
26
Carcinoma, Transitional Cell
24
Small Cell Lung Carcinoma
23
Uterine Cervical Dysplasia
22
Sarcoma
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Urologic Neoplasms
×
Gynecologic
×
90 days
×
Clear all
NCT06238479
2026-05-22
EXCEED
Eli Lilly and Company
Phase 1
Active not recruiting
490 enrolled
NCT06465069
2026-05-22
NEXUS-01
Eli Lilly and Company
Phase 1
Recruiting
420 enrolled